{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T03:12:52Z","timestamp":1649128372043},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1590\/s0104-42302012000500010","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T08:13:14Z","timestamp":1350720794000},"page":"543-549","source":"Crossref","is-referenced-by-count":2,"title":["Efeitos colaterais do tratamento da hepatite C no polo aplicador do ABC"],"prefix":"10.1016","volume":"58","author":[{"given":"Thamy Jay","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique","family":"Schmidt Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tauy Pereira","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Higasiaraguti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9ia Maruzo","family":"Perej\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munir Akar","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1590\/S0104-42302012000500010_bib1","unstructured":"Centers for Disease Control and Prevention (CDC). Hepatitis C information for the public. Atlanta; 2009 [citado julho 2011]. Dispon\u00edvel em: http:\/\/www.cdc.gov\/hepatitis\/C\/index.htm."},{"key":"10.1590\/S0104-42302012000500010_bib2","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil), Secret\u00e1ria de Vigil\u00e2ncia em Sa\u00fade, Departamento de DST, Aids e Hepatites Virais. Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite viral C e coinfec\u00e7\u00f5es. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2011. [S\u00e9rie A. Normas e manuais t\u00e9cnicos]."},{"key":"10.1590\/S0104-42302012000500010_bib3","unstructured":"World Health Organization (WHO). Hepatitis C \u2013 2002. Geneve: WHO; 2003 [citado julho 2011]. Dispon\u00edvel em: http:\/\/www.who.int\/csr\/disease\/hepatitis\/Hepc.pdf."},{"key":"10.1590\/S0104-42302012000500010_bib4","series-title":"Sociedade Brasileira de Infectologia (SBI). I Consenso da Sociedade Brasileira de Infectologia para o Manuseio e Terapia da Hepatite C","article-title":"Hepatite por VHC \u2013 aspectos vir\u00f3ticos e suas implica\u00e7\u00f5es pr\u00e1ticas","author":"Barone","year":"2008"},{"key":"10.1590\/S0104-42302012000500010_bib5","series-title":"Public health challenges for controlling HCV infection","year":"2005"},{"key":"10.1590\/S0104-42302012000500010_bib6","series-title":"Boletim epidemiol\u00f3gico: hepatites virais","year":"2010"},{"key":"10.1590\/S0104-42302012000500010_bib7","first-page":"24","article-title":"Sociedade Brasileira de Infectologia (SBI). I Consenso da Sociedade Brasileira de Infectologia para o Manuseio e Terapia da Hepatite C","year":"2008"},{"key":"10.1590\/S0104-42302012000500010_bib8","series-title":"Sociedade Paulista de Infectologia. II Consenso da Sociedade Paulista de Infectologia para Manuseio e Terapia da Hepatite C","first-page":"32","article-title":"Hepatite C aguda","author":"Angerami","year":"2004"},{"key":"10.1590\/S0104-42302012000500010_bib9","unstructured":"Sociedade Brasileira de Infectologia (SBI). Hepatites virais cr\u00f4nicas: diagn\u00f3stico e tratamento atual. Boletim Terap\u00eautico de HIV\/AIDS, DST e Hepatites Virais 2003; 1(4)."},{"key":"10.1590\/S0104-42302012000500010_bib10","series-title":"Sociedade Brasileira de Infectologia (SBI). I Consenso da Sociedade Brasileira de Infectologia para o Manuseio e Terapia da Hepatite C","article-title":"Tratamento da hepatite C em pacientes virgens de tratamento","author":"Ferreira","year":"2008"},{"issue":"2","key":"10.1590\/S0104-42302012000500010_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jhep.2001.21747","article-title":"Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in non cirrhotic patients with chronic hepatitis C","volume":"33","author":"Reddy","year":"2001","journal-title":"Hepatology"},{"issue":"39","key":"10.1590\/S0104-42302012000500010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8390","article-title":"Pegylated IFN-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation","volume":"8","author":"Shepherd","year":"2004","journal-title":"Health Technol Assess"},{"issue":"10","key":"10.1590\/S0104-42302012000500010_bib13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.cgh.2010.06.019","article-title":"Meta-analysis shows extended therapy improves response of patients with chronic hepatitis C virus genotype 1 infection","volume":"8","author":"Farnik","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1590\/S0104-42302012000500010_bib14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/j.gastro.2006.02.015","article-title":"Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin","volume":"130","author":"Berg","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1590\/S0104-42302012000500010_bib15","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.21919","article-title":"Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis C genotype 1-infected slow responders","volume":"46","author":"Pearlman","year":"2007","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1590\/S0104-42302012000500010_bib16","first-page":"S243","article-title":"How can we identify HCV genotype 1 patients who may benefit from an extended treatment duration with peginterferon alfa-2a (40kd) plus RBV?","volume":"46","author":"Sanchez-Tapias","year":"2007","journal-title":"J Hepatol"},{"issue":"2","key":"10.1590\/S0104-42302012000500010_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/j.gastro.2009.10.058","article-title":"Peginterferon alfa-2a\/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virological response","volume":"138","author":"Ferenci","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1590\/S0104-42302012000500010_bib18","first-page":"346","article-title":"Peginterferon-2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Stephanos","year":"2004","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1590\/S0104-42302012000500010_bib19","first-page":"281","article-title":"Perspectives on fibrosis progression in hepatitis C: an a la carte approach to risk factors and staging of fibrosis","volume":"15","author":"Poynard","year":"2010","journal-title":"AntivirTher"},{"issue":"4","key":"10.1590\/S0104-42302012000500010_bib20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Seeff. AASLD practice guidelines: diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1590\/S0104-42302012000500010_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1590\/S0100-879X2005000100007","article-title":"Geographic distribution of hepatitis C virus genotypes in Brazil","volume":"38","author":"Campiotto","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.1590\/S0104-42302012000500010_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2011.02706.x","article-title":"Barriers to hepatitis C treatment","volume":"32","author":"McGowan","year":"2012","journal-title":"Liver Int"},{"issue":"1","key":"10.1590\/S0104-42302012000500010_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1478-3231.2011.02705.x","article-title":"Treatment of chronic hepatitis C: are interferons really necessary?","volume":"32","author":"Ferenci","year":"2012","journal-title":"Liver Int"},{"issue":"1","key":"10.1590\/S0104-42302012000500010_bib24","first-page":"29","article-title":"Hepatitis C virus: current concepts and future challenges","volume":"105","author":"Klenerman","year":"2012","journal-title":"Int J Med"},{"issue":"1","key":"10.1590\/S0104-42302012000500010_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0037-86822001000100011","volume":"34","author":"Strauss","year":"2001","journal-title":"Rev Soc Bras Med Trop"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0104423012702476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0104423012702476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v58n5\/en_v58n5a10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T21:51:57Z","timestamp":1542664317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0104423012702476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0104423012702476"],"URL":"https:\/\/doi.org\/10.1590\/s0104-42302012000500010","relation":{},"ISSN":["0104-4230"],"issn-type":[{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}